If you made any changes in Pure these will be visible here soon.

Research Output 1979 2019


Erratum: T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells (Cancer Cell (2016) 30(3) (377–390)(S1535610816303890)(10.1016/j.ccell.2016.08.004))

Marigo, I., Zilio, S., Desantis, G., Mlecnik, B., Agnellini, A. H. R., Ugel, S., Sasso, M. S., Qualls, J. E., Kratochvill, F., Zanovello, P., Molon, B., Ries, C. H., Runza, V., Hoves, S., Bilocq, A. M., Bindea, G., Mazza, E. M. C., Bicciato, S., Galon, J., Murray, P. J. & 1 others, Bronte, V., Oct 10 2016, In : Cancer Cell. 30, 4, p. 651 1 p.

Research output: Contribution to journalComment/debate

CD40 Ligand
Nitric Oxide Synthase Type II
Cell- and Tissue-Based Therapy
Dendritic Cells
Tumor Necrosis Factor-alpha